SCHEMBL6993028

SCHEMBL6993028

COc1nn(C(C)CCCc2ccccc2)c2nc(Cc3ccccc3)[nH]c(=O)c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 5/20 0.47
CCNE1 P24864 3/20 0.41
CDK2 P24941 3/20 0.41
CCNE2 O96020 2/20 0.41
CDK4 P11802 2/20 0.41
CCND1 P24385 2/20 0.41
CCNB2 O95067 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CCNB3 Q8WWL7 1/20 0.41
RNASEH1 O60930 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
KMT2A Q03164 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
CCNK O75909 1/20 0.39
CCND3 P30281 1/20 0.39
GSK3B P49841 1/20 0.39
CDK7 P50613 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6991709 0.92 PDE2A (0.58) PDE2ACCNE1CDK2CCNE2CDK4
SCHEMBL6991547 0.90 PDE2A (0.49) PDE2ACCNE1CDK2CCNE2CDK4
SCHEMBL6999205 0.81 CCNE2 (0.48) PDE2ACCNE1CDK2CCNE2CDK4
SCHEMBL6998944 0.81 CCNE2 (0.54) CCNE1CDK2CCNE2CDK4CCND1
SCHEMBL6998879 0.79 PDE2A (0.44) PDE2ACCNE1CDK2CCNE2CDK4
SCHEMBL6987648 0.78 PDE2A (0.47) PDE2ACCNE1CDK2CCNE2CDK4
SCHEMBL7892414 0.78 CCNE1 (0.42) PDE2ACCNE1CDK2CCNE2CDK4
SCHEMBL6992823 0.78 PDE9A (0.53) PDE2AKMT2A
SCHEMBL2831825 0.78 PDE2A (0.46) PDE2ARNASEH1KMT2AADORA3
SCHEMBL7355722 0.77 ADORA3 (0.48) PDE2ACCNE1CDK2CCNE2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973774-B1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2003-01-22 EP disclosed
US-6174884-B1 CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 2001-01-16 US disclosed